Investor Advantech Capital L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Advantech Capital L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-07-14 13D/A SVA / Sinovac Biotech, Ltd. 5,851,423 5,851,423
2025-04-10 13D/A SVA / Sinovac Biotech, Ltd. 5,851,423 5,851,423
2025-03-25 13D SVA / Sinovac Biotech, Ltd. 5,851,423 5,851,423
2025-02-26 13G/A EM / Smart Share Global Limited - Depositary Receipt (Common Stock) 34,020,246 0
2024-03-20 13G/A SVA / Sinovac Biotech, Ltd. 5,900,000 5,851,423
2024-02-05 13G/A EM / Smart Share Global Limited - Depositary Receipt (Common Stock) 34,158,716 34,020,246
2023-02-08 13G/A EM / Smart Share Global Limited - Depositary Receipt (Common Stock) 34,765,873 34,158,716
2022-02-15 13G / SMART SHARE GLOBAL LTD ADR 34,765,873
2021-02-09 13G/A ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock) 4,551,772 2,222,681
2020-02-11 13G/A ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock) 7,167,397 4,551,772
2018-07-10 13G SVA / Sinovac Biotech, Ltd. 5,900,000
2018-02-13 13G ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock) 7,167,397